Envase
Envase
Empaque tipo blíster de al menos un producto farmacéutico o suplemento alimenticio de tipo goma
29/07/2022 -
La invención proporciona un empaque tipo blíster (1) para al menos un producto farmacéutico o suplemento alimenticio de tipo goma, que comprende una carcasa de soporte (12) que tiene una parte...
NUCLEIC ACID TRANSPORTERS IN NANOCHAIN FORM, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR CANCER GENE THERAPY, COMPRISING SAME
28/07/2022 -
The present invention relates to a polydixylitol polymer nucleic acid transporter (X-NC) prepared in a nanochain form, a method for preparing same, and a technology for treating brain tumors by...
DEGRADERS OF GRK2 AND USES THEREOF
28/07/2022 -
Provided herein are compounds (e.g., compounds of Formulae (A-I), (B-I), (C-I)), and pharmaceutically acceptable salts, stereoisomers, tautomers, isotopically labeled derivatives, solvates,...
NUEVA SAL Y FORMAS CRISTALINAS
22/06/2022 -
Esta invención se refiere a una sal de hemi-fumarato del ácido 1-(4-{1-[(E)-4-ciclohexil-3-trifluoro-metil-benciloxi-imino]-etil}-2-etil-bencil)-azetidin-3-carboxílico (Compuesto I), a...
FORMULACIONES DE UN AGONISTA DEL RECEPTOR FARNESOIDE X
22/06/2022 -
En el presente documento se describen las formulaciones farmacéuticas de un agonista del receptor farnesoide X, 3-hidroxiazetidina-trans-1-carboxilato de...
COMPOSICIONES POLIMÉRICAS PARA ADMINISTRACIÓN INTRANASAL
22/06/2022 -
Se describe una composición en forma de polvo seco para administración intranasal que comprende partículas sólidas, cada una con un polímero mucoadhesivo fisiológicamente aceptable en...
DISPERSIONES SÓLIDAS DE (R)-1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-IL)-N-(1-(2,3-DIHIDROXIPROPIL)-6-FLUORO-2-(1-HIDROXI-2-METILPROPAN-2-IL)-1H-INDOL-5-IL), SUS COMPOSICIONES Y MÉTODOS PARA PREPARAR LAS DISPERSIONES SÓLIDAS
22/06/2022 -
Dispersión sólida que comprende (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-N-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1H-indol-5-il)ciclopropancarboxamida...
ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT
21/07/2022 -
Drug tablets that include a controlled release layer of a moisture-sensitive active agent are prepared with a lipidic matrix forming excipient, a water-soluble, channel forming excipient and a...
ANTI-VIRAL AGENT USED IN UPPER RESPIRATORY TRACT VIRAL INFECTIONS AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
21/07/2022 -
The present invention relates to an anti-viral agent for the treatment and prophylaxis of upper respiratory tract infections caused by viral (Rhinoviruses, Coronaviruses including Covid-19,...
FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE
21/07/2022 -
Provided is a starch film-forming composition, comprising: A, a first gelling agent; B, starch; C, a plasticizer; D, water; wherein the first gelling agent is a gellan gum with two gel...
FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE
21/07/2022 -
Provided is a starch film-forming composition, comprising: A, a first gelling agent; B, starch; C, a plasticizer; D, water; wherein the first gelling agent is a gellan gum with two gel...
ANTI-VIRAL AGENT USED IN UPPER RESPIRATORY TRACT VIRAL INFECTIONS AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
21/07/2022 -
The present invention relates to an anti-viral agent for the treatment and prophylaxis of upper respiratory tract infections caused by viral (Rhinoviruses, Coronaviruses including Covid-19,...
CROSSLINKED BUTYRATE OR BUTYRATE-FORMATE DERIVATIVES OF HYALURONIC ACID AND THE CROSSLINKING PROCESS THEREOF
27/05/2021 -
The present invention relates to a process for the preparation of crosslinked hyaluronic acid butyrate or crosslinked hyaluronic acid butyrate-formate or an acceptable salt thereof, wherein the...
Composición farmacéutica en base a thc y cbd para el tratamiento del dolor crónico refractario
19/07/2022 -
Se provee una composición farmacéutica natural o fitofármaco, formulado a partir de la planta Cannabis sativa L. que proporciona al paciente una terapia efectiva y segura para tratar el dolor...
Formulaciones de liberación sostenida con emulsiones no acuosas
19/07/2022 -
Se proporcionan métodos de emulsión no acuosa para producir micropartículas poliméricas o revestidas con polímeros. Un método produce una composición de micropartícula de liberación...
Compuestos tricíclicos sustituidos
19/07/2022 -
Se divulgan compuestos de fórmula general (I), su forma tautomérica, su estereoisómero, su sal farmacéuticamente aceptable, su polimorfo o solvato del mismo, en donde, el anillo A, de R1 a R5,...
MATERIAL FOR TREATING INFLAMATION OF GULLET AND INFLAMATION AND ULCER OF GASTRIC-BOWELS
27/01/1997 -
This invention describes the use of dimethylpolysyloxane for the treatment of inflammations of the gullet, inflammations and ulcers of the digestive-intestine systems, for example inflammation of...
STABLE GEL COMPOSITION HAVING HIGH OIL CONTENT, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
14/07/2022 -
A chewable stable gel composition having a high oil content, comprising, on the basis of the total weight of the composition, 55-70 wt % oil, 1-15 wt % first gelling agent, 0.1-2 wt % second...
MULTIKINASE INHIBITOR AND USE THEREOF
14/07/2022 -
A multikinase inhibitor and use thereof, a compound of formula I, and an isotope form, a stereoisomer form, a tautomer form, a pharmaceutically acceptable salt, a pharmaceutically acceptable...
NOVEL INHIBITORS OF AUTOTAXIN
14/07/2022 -
The present invention relates to compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, and polymorphs. The...
Composição aquosa para prevenir, inibir ou tratar infecção e respectivo uso
03/10/2017 -
composição aquosa para prevenir, inibir ou tratar infecção, respectivo uso e método para prevenir e/ou tratar infecções composições compreendendo uma mistura de um polipeptídeo...
